Pierre Fabre Limited

Hyde Abbey House, 23 Hyde Street, Winchester, Hampshire, SO23 7DR
Telephone: +44 (0)1962 874 400
Fax: +44 (0)1962 844 014
Medical Information Direct Line: +44 (0)1962 874 435
Medical Information e-mail: medicalinformation@pierre-fabre.co.uk
Customer Care direct line: +44 (0)1962 874 402
Medical Information Fax: +44 (0)1962 874 413

Patient Information Leaflet last updated on the eMC: 01/03/2011
PIL Navelbine 10 mg / ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Change to warnings or special precautions for use
Updated on 11/11/2010 and displayed until 01/03/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to, or new, use for medicine
Updated on 24/08/2009 and displayed until 11/11/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 22/08/2006 and displayed until 24/08/2009
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
Updated on 20/05/2005 and displayed until 22/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   vinorelbine tartrate